Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-011763
Filing Date
2022-11-23
Accepted
2022-11-23 18:57:53
Documents
1
Period of Report
2022-11-22

Document Format Files

Seq Description Document Type Size
1 form4-11232022_111144.html 4  
1 form4-11232022_111144.xml 4 3402
  Complete submission text file 0001415889-22-011763.txt   4794
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PERRIGO COMPANY PLC 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address
O'Connor Donal (Reporting) CIK: 0001625377 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 221417362